BCL9 and neoplasm: Although no major histomorphologic differences were observed between engrafted wild-type and BCL9 knockout RKO cells, the tumor cell component in RKO wild-type engrafted tumors was more heterogeneous than in RKO BCL9 knockout engrafted tumors (Fig. 6b, bottom).